YL

Yanke Liang

DI Dana-Farber Cancer Institute: 2 patents #10 of 192Top 6%
CT C4 Therapeutics: 1 patents #8 of 27Top 30%
Hoffmann-La Roche: 1 patents #77 of 347Top 25%
TI The Broad Institute: 1 patents #60 of 207Top 30%
The General Hospital: 1 patents #84 of 426Top 20%
📍 Belmont, MA: #14 of 223 inventorsTop 7%
🗺 Massachusetts: #830 of 14,338 inventorsTop 6%
Overall (2023): #36,152 of 537,848Top 7%
4
Patents 2023

Issued Patents 2023

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11827636 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski 2023-11-28
11725011 Bicyclic urea kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi, Thomas Sundberg, Alykhan Shamji, Ramnik Xavier +2 more 2023-08-15
11708354 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds Martin Duplessis, Georg Jaeschke, Bernd Kuhn, Kiel Lazarski, Yvonne Alice Nagel +3 more 2023-07-25
11673902 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Alexander Hird, Ryan E. Michael +5 more 2023-06-13